Global Atherectomy Systems Market Segmentation, By Product (Directional Atherectomy, Orbital Atherectomy, Photo-Ablative (Laser) Atherectomy, Rotational Atherectomy and Support Devices), Application (Peripheral Vascular, Cardiovascular, Neurovascular and Others), End User (Hospitals and Surgical Centres, Ambulatory Care Centres, Research Laboratories and Academic Institutes and Others) - Industry Trends and Forecast to 2031
Atherectomy Systems Market Analysis
Atherectomy equipment is used to remove plaque and thrombus from the arteries. Atherosclerosis of the peripheral and coronary arteries is treated with atherectomy systems. Plaque or thrombus builds up in the arteries, preventing blood from flowing freely. As a result, in order to speed the workflow, a patient must undergo atherectomy, which necessitates the employment of atherectomy technology.
Atherectomy Systems Market Size
Global Atherectomy Systems Market size was valued at USD 599.40 million in 2023 and is projected to reach USD 1014.58 million by 2031, with a CAGR of 6.80% during the forecast period of 2024 to 2031.
Report Scope and Market Segmentation
|
Attributes
|
Atherectomy Systems Key Market Insights
|
|
Segmentation
|
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Key Market Players
|
BD (US), Medtronic (Ireland), Koninklijke Philips N.V. (Netherlands), Cardinal Health. (US), Cardiovascular Systems, Inc. (US), Boston Scientific Corporation (US), Minnetronix Medical Inc. (US), Avinger. (US), Straub Medical AG (Switzerland), Biomerics. (US), Biotronik (Germany), Ra Medical Systems (US), Terumo Corporation (Japan), Abbott (US), B. Braun Melsungen AG (Germany), Covidien (Ireland), Spectranetics (US), Baxter (US), Bayer AG (Germany) and Getinge AB (Sweden)
|
|
Market Opportunities
|
|
Global Atherectomy Systems Market Definition
Plaque and thrombus are removed from the arteries using atherectomy equipment. The atherectomy systems are used to treat disorders of the peripheral and coronary arteries. The buildup of plaque or thrombus in the arteries prevents blood from flowing freely. As a result, a patient must undergo atherectomy to streamline the workflow, necessitating the use of atherectomy technologies.
Atherectomy Systems Market Dynamics
Drivers
- Rise in the preference for minimally invasive procedure
The gadgets are in high demand because to the growing trend of minimally invasive surgeries, which do less damage to the body than traditional medical procedures.
- Increase in the target patient population
Growing number of geriatric residents around the world. According to the National Health and Nutrition Examination Survey, around 6% of adults over the age of 40 have PAD, which translates to approximately 7 million patients in the United States alone and nearly 200 million worldwide.
- Technological developments
Advances in endovascular technology have made it possible to handle peripheral and coronary vascular disorders with a minimally invasive percutaneous approach in the majority of patients who previously required an invasive procedure.
Opportunities
In addition, the growing incidence of peripheral arterial diseases are further estimated to provide potential opportunities for the growth of the atherectomy systems market in the coming years.
Restraints/Challenges
On the other hand, the strict regulations and increased cost of the product is further projected to impede the growth of the atherectomy systems market in the targeted period. However, the dearth of skilled healthcare professionals might further challenge the growth of the atherectomy systems market in the near future.
This atherectomy systems market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the atherectomy systems market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Covid-19 Impact on Atherectomy Systems Market
The COVID-19 had a negative impact on the atherectomy systems market. During the epidemic, social isolation and limitations severely impacted businesses and activities, causing transportation and logistical problems around the world. Due to the rapid emergence of the COVID-19 pandemic, several elective cardiovascular procedures were cancelled or postponed to reduce the risk of coronavirus infection during hospital visits. Furthermore, supply effects were exacerbated by lower discretionary income. However, once the epidemic is gone, there is a beneficial impact on the market.
Atherectomy Systems Market Scope
The atherectomy systems market is segmented on the basis of product, application and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Directional Atherectomy
- Orbital Atherectomy
- Photo-Ablative (Laser) Atherectomy
- Rotational Atherectomy
- Support Devices
Application
- Peripheral Vascular
- Cardiovascular
- Neurovascular
- Others
End User
- Hospitals and Surgical Centres
- Ambulatory Care Centres
- Research Laboratories
- Academic Institutes
- Others
Atherectomy Systems Market Regional Analysis
The atherectomy systems market is analysed and market size insights and trends are provided by country, product, application and end user as referenced above.
The countries covered in the atherectomy systems market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the atherectomy systems market due to the rise in the expenditure for research and development. Furthermore, the growing incidence of cardiovascular diseases will further boost the growth of the atherectomy systems market in the region during the forecast period.
Asia-Pacific is projected to observe significant amount of growth during the forecast period of 2024 to 2031 due to the rise in the patient awareness. Moreover, the enhancing healthcare infrastructure is further anticipated to propel the growth of the atherectomy systems market in the region in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Atherectomy Systems Market Share
The atherectomy systems market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to atherectomy systems market.
Atherectomy Systems Market Leaders Operating in the Market Are:
- BD (US)
- Medtronic (Ireland)
- Koninklijke Philips N.V. (Netherlands)
- Cardinal Health. (US)
- Cardiovascular Systems, Inc. (US)
- Boston Scientific Corporation (US)
- Minnetronix Medical Inc. (US)
- Avinger. (US)
- Straub Medical AG (Switzerland)
- Biomerics. (US)
- Biotronik (Germany)
- Ra Medical Systems (US)
- Terumo Corporation (Japan)
- Abbott (US)
- B. Braun Melsungen AG (Germany)
- Covidien (Ireland)
- Spectranetics (US)
- Baxter (US)
- Bayer AG (Germany)
- Getinge AB (Sweden)
Latest Developments in Atherectomy Systems Market
- Cardiovascular Systems, Inc. gained CE Mark for the Diamondback 360 Coronary Orbital Atherectomy System in January 2021. (OAS). The device has GlideAssist, which allows for better device tracking, repositioning, and removal, especially during difficult procedures, and may be used to treat a variety of calcium modalities. The company's product portfolio will be expanded as a result of the strategic move
SKU-